Cascini Fidelia, Pantovic Ana, Al-Ajlouni Yazan, Failla Giovanna, Ricciardi Walter
Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome 00168, Italy.
Faculty of Biology, University of Belgrade, Belgrade, Serbia.
EClinicalMedicine. 2021 Oct;40:101113. doi: 10.1016/j.eclinm.2021.101113. Epub 2021 Sep 2.
High rates of vaccination worldwide are required to establish a herd immunity and stop the current COVID-19 pandemic evolution. Vaccine hesitancy is a major barrier in achieving herd immunity across different populations. This study sought to conduct a systematic review of the current literature regarding attitudes and hesitancy to receiving COVID-19 vaccination worldwide.
A systematic literature search of PubMed and Web of Science was performed on July 5th, 2021, using developed keywords. Inclusion criteria required the study to (1) be conducted in English; (2) investigate attitudes, hesitancy, and/or barriers to COVID-19 vaccine acceptability among a given population; (3) utilize validated measurement techniques; (4) have the full text paper available and be peer-reviewed prior to final publication.
Following PRISMA guidelines, 209 studies were included. The Newcastle Ottawa (NOS) scale for cross-sectional studies was used to assess the quality of the studies.Overall, vaccine acceptance rates ranged considerably between countries and between different time points, with Arabian countries showing the highest hesitancy rates compared with other parts of the world.
A variety of different factors contributed to increased hesitancy, including having negative perception of vaccine efficacy, safety, convenience, and price. Some of the consistent socio-demographic groups that were identified to be associated with increased hesitancy included: women, younger participants, and people who were less educated, had lower income, had no insurance, living in a rural area, and self-identified as a racial/ethnic minority.
全球需要高疫苗接种率来建立群体免疫并阻止当前新冠疫情的演变。疫苗犹豫是在不同人群中实现群体免疫的主要障碍。本研究旨在对当前有关全球范围内对新冠疫苗接种的态度和犹豫情况的文献进行系统综述。
2021年7月5日,使用拟定的关键词对PubMed和科学网进行了系统的文献检索。纳入标准要求研究(1)以英文进行;(2)调查特定人群中对新冠疫苗可接受性的态度、犹豫情况和/或障碍;(3)采用经过验证的测量技术;(4)有全文且在最终发表前经过同行评审。
遵循PRISMA指南,纳入了209项研究。采用纽卡斯尔渥太华(NOS)横断面研究量表来评估研究质量。总体而言,各国之间以及不同时间点的疫苗接受率差异很大,与世界其他地区相比,阿拉伯国家的犹豫率最高。
多种不同因素导致犹豫情况增加,包括对疫苗效力、安全性、便利性和价格的负面看法。一些被确定与犹豫情况增加相关的一致的社会人口学群体包括:女性、年轻参与者、受教育程度较低、收入较低、没有保险、居住在农村地区且自我认定为少数种族/族裔的人群。